Geron Corp (NASDAQ: GERN) on Monday, plunged -3.75% from the previous trading day, before settling in for the closing price of $2.93. Within the past 52 weeks, GERN’s price has moved between $1.64 and $5.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 72.04%. The company achieved an average annual earnings per share of 21.15%. With a float of $564.59 million, this company’s outstanding shares have now reached $603.10 million.
The extent of productivity of a business whose workforce counts for 141 workers is very important to gauge. In terms of profitability, gross margin is 96.53%, operating margin of -705.46%, and the pretax margin is -682.48%.
Geron Corp (GERN) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Geron Corp is 6.60%, while institutional ownership is 78.78%. The most recent insider transaction that took place on Jul 08 ’24, was worth 3,073,004. In this transaction EVP, Chief Operating Officer of this company sold 674,348 shares at a rate of $4.56, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’24, when Company’s EVP, Chief Medical Officer sold 287,900 for $4.63, making the entire transaction worth $1,334,129. This insider now owns 0 shares in total.
Geron Corp (GERN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.15% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Geron Corp (GERN) is currently performing well based on its current performance indicators. A quick ratio of 2.74 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 57.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.32, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.06 in one year’s time.
Technical Analysis of Geron Corp (GERN)
The latest stats from [Geron Corp, GERN] show that its last 5-days average volume of 13.23 million was superior to 11.19 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 38.32%. Additionally, its Average True Range was 0.15.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 2.91%, which indicates a significant decrease from 16.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.24% in the past 14 days, which was lower than the 43.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.41, while its 200-day Moving Average is $4.06. Now, the first resistance to watch is $2.93. This is followed by the second major resistance level at $3.05. The third major resistance level sits at $3.13. If the price goes on to break the first support level at $2.73, it is likely to go to the next support level at $2.65. Assuming the price breaks the second support level, the third support level stands at $2.53.
Geron Corp (NASDAQ: GERN) Key Stats
Market capitalization of the company is 1.70 billion based on 604,501K outstanding shares. Right now, sales total 240 K and income totals -184,130 K. The company made 28,270 K in profit during its latest quarter, and -26,450 K in sales during its previous quarter.
